小鼠模型市場:各類型，各類服務，各技術，各用途，各終端用戶，各地區，2024年～2031年

2024-2031 年小鼠模型市場評估

增加對製藥計畫的研發投資，特別是在腫瘤學和個人化治療方面，正在推動對改善小鼠模型的需求。因此，製藥業對小鼠模型日益增長的需求將有助於市場超過2023年的16.3億美元的收入，並在2031年達到26.4億美元的預期估值。

此外，由於在進入人體試驗臨床階段之前需要準確、高效地篩選和測試藥物的有效性和安全性，該市場從 2024 年到 2031 年將以 6.23% 的複合年增長率增長。

小鼠模型市場定義/概述

小鼠模型是在科學研究中使用小鼠（Musculus）來再現和研究人類生物學、生理學和疾病的各個方面。小鼠和人類在遺傳、生化和行為上相似，使用這些模型是因為它們提供了對基因功能、疾病進展和未來治療評估的有用見解。

此外，小鼠模型在生物醫學研究中發揮重要作用，因為它們使科學家能夠了解人類疾病並在受控環境中測試新療法。小鼠模型常用於癌症研究、神經學、免疫學、遺傳學等。小鼠模型正在幫助研究人員了解疾病的複雜性、識別遺傳變數並開發標靶藥物。

生物醫學研究中對小鼠模型的需求不斷增加是否會導緻小鼠模型銷售量的激增？

小鼠模型在藥物發現的臨床前測試階段的越來越多的應用預計將在未來幾年推動市場成長。此外，政府對製藥業發展的支持和投資的增加預計也將永久改變市場的成長軌跡。

對客製化治療的日益關注增加了對反映個體遺傳特徵和疾病特徵的小鼠模型的需求。具有人源化免疫系統和特定突變的先進小鼠模型正在促進小鼠模型市場對成功的客製化治療的高需求。

此外，有些國家在動物實驗過程中越來越需要遵守嚴格的法規，也是小鼠模型市場的主要驅動因素。在批准新藥和治療方法之前，需要對動物進行臨床前測試，這增加了對可靠且多樣化的小鼠模型的需求，以進行功效和安全性研究，從而推動市場發展。

限制小鼠模型在科學研究中使用的限制是什麼？

越來越多地使用動物模型進行研究和開發，引起了人們對動物屠宰和進一步人類應用的效率風險的擔憂。這個與獸醫相關的倫理問題不僅需要監管審查，而且引起了公眾的關注。對更多動物模型的需求是對小鼠模型市場的挑戰。

培育和維持高品質小鼠模型（尤其是基因工程小鼠模型）的高成本和複雜性，是預算有限的小型研究機構和公司的主要障礙。這些障礙，再加上所需的財務投資和專業知識，影響了對小鼠模型的需求。

此外，不同地區監管環境的差異可能會導致專案進度複雜化和延誤。預計這種區域差異將阻礙小鼠模型市場的成長。

目錄

第1章 簡介

• 市場定義
• 市場區隔
• 調查計劃
• 前提條件
• 限制

第2章 調查手法

• 資料探勘
• 2次調查
• 1次調查
• 專家的建議
• 品質檢查
• 最後檢討
• 資料的三角測量
• Bottom-Up(由下而上)方法
• Top-Down(由上而下)方法
• 調查的流程
• 資料來源

第3章 摘要整理

• 市場概要
• 小鼠模型的全球市場各地區分析(年複合成長率)
• 小鼠模型的全球市場:各類型(金額)
• 小鼠模型的全球市場:各類服務(金額)
• 小鼠模型的全球市場:各技術(金額)
• 小鼠模型的全球市場:各應用領域(金額)
• 今後的市場機會
• 全球市場明細

第4章 市場展望

• 小鼠模型的全球市場展望
  • 推動市場要素
  • 多項醫藥研發活動
• 市場限制因素
  • 有關在研究中道德使用動物的法規和法律
• 市場機會
  • Crisple 作為強大工具的出現
• 波特的五力分析

第5章 各類型市場

• 概要
• 近交系小鼠
• 非 BRED 小鼠
• 基因改造小鼠
• 有條件/經過手術改造的小鼠
• 其他

第6章 各類服務市場

• 概要
• 育種
• 冷凍保存
• 隔離
• 基因檢測
• 其他

第7章 各技術市場

• 概要
• crispr/cas9 顯微注射
• 顯微注射
• 核轉移
• 胚胎幹細胞注射
• 其他

第8章 各用途市場

• 概要
• 腫瘤研究
• 糖尿病研究
• 心血管研究
• 免疫·發炎研究
• 中樞神經系統研究
• 其他的疾病研究

第9章 各地區市場

• 概要
• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 其他
  • 南美·中東

第10章 競爭情形

• 概要
• 主要的開發策略
• 企業排行榜分析

第11章 企業簡介

• LABORATORY CORPORATION OF AMERICA HOLDINGS
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
• THE JACKSON LABORATORY
• JANVIER LABS
• HARBOUR ANTIBODIES BV
• TRANS GENIC, INC.
• GENOWAY
• TACONIC BIOSCIENCES, INC.
• ENVIGO

Mice Model Market Valuation - 2024-2031

Rising investments in research and development taking place in pharmaceutical projects, especially in oncology and personalized treatment, are driving up the demand for improved mouse models. Thus, growing demand for mice models from the pharmaceutical industry is estimated to help the market surpass the revenue of USD 1.63 Billion valued in 2023 to reach a valuation of USD 2.64 Billion over the forecast 2031.

Also, the need for accurate and efficient screening and testing of drug efficacy and safety before reaching the clinical phase of human trials enables the market to grow at aCAGR of 6.23% from 2024 to 2031.

Mice Model Market: Definition/ Overview

A mice model is the use of mice (Mus musculus) in scientific research to replicate and investigate many aspects of human biology, physiology, and illness. These models are used because mice and humans have genetic, biochemical, and behavioral similarities, which provide useful insights into gene function, illness progression, and the evaluation of prospective therapies.

Furthermore, mice models serve an important role in biomedical research because they allow scientists to comprehend human diseases and test new treatments in a controlled setting. They are commonly used in cancer research, neurology, immunology, and genetics. Mice models assist researchers in understanding the intricacies of diseases, identifying genetic variables, and developing targeted medicines.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Increased Need for Mice Models in Biomedical Research Upsurge Sales of Mice Model?

The rising application of the mice model in the preclinical testing phase of drug discovery is expected to enhance the growth of the market in the coming years. Also, increasing government support and investments in the development of the pharmaceutical industry is expected to create a completely upward scaling growth trajectory of the market.

The increased emphasis on customized treatment underlines the need for mice models that reflect individual genetic profiles and disease characteristics. Advanced mice models with humanized immune systems and particular mutations are fostering a high demand for successful tailoring treatment in the Mice Model Market.

Furthermore, the increasing need for compliance with stringent regulations during animal testing in some countries is a primary driver for the Mice Model Market. Mandatory preclinical testing in animals before the approval of new medications and therapies increases the demand for trustworthy and diverse mouse models for efficacy and safety studies developing the market.

Which are the Limitations Restraining the Use of Mice Models in Scientific Research?

The rising use of animal models for research and development is raising concerns regarding animal slaughtering and the risks of efficiency for further human application. This ethical issue associated with animal care is increasing public concern as well as insisting on revising the regulations. The demand for animal models in higher numbers is posing a challenge for the Mice Model Market.

The high costs and complications of breeding and maintaining high-quality mice models, particularly genetically engineered ones, act as a major barrier for the budget-constrained smaller research institutions and businesses. These hurdles increase with the necessary financial investment and specialized knowledge impacting the demand for the mice models.

Furthermore, the different regulatory environments practiced in diverse regions is likely to complicate and slow down project schedules, and also strict restrictions controlling animal research are raising costs. These inconsistencies among regions are projected to hamper the growth of the Mice Model Market.

Category-Wise Acumens

How will Rise in Adoption of CRISPR/CAS9 Technology Fare for Mice Model Market?

According to VMR analysts, the CRISPR/CAS9 segment is estimated to hold the largest market share during the forecast period. The advantageous properties including precision, efficiency, versatility, cost-effectiveness, and metamorphic nature offered by this solution is estimated to improve genetic research.

CRISPR/Cas9's unmatched precision and efficiency in gene editing allow researchers to develop extremely specialized and adaptable mouse models, thereby transforming the area of genetic manipulation. The simplicity and adaptability of this technology resulted in its dominance, allowing scientists to target and change genes with unprecedented precision in the Mice Model Market.

Furthermore, the cost-effectiveness and ease of implementation of CRISPR/Cas9 when compared to traditional techniques is accelerating its widespread adoption. Thus, this technology is proving favorable in the case of producing genetically modified mice.

Why does Application in Field of Oncology Prove Resourceful for Mice Model Market?

The oncology segment is estimated to dominate the Mice Model Market over the forecast period. Growing emphasis on complex cancer research activities is bolstering the use of genetically related mice models, especially guinea pigs, enabling mice models to gain momentum in the field of precision oncology.

Likewise, the use of efficient animal models to investigate the complexities of oncogenesis and evaluate the prospective treatment strategies are projected to result in the expansion of the market. Because of their genetic resemblance to humans and their propensity for tumor formation, mice are useful models for studying many facets of cancer biology further resulting in the dominance of oncology application in the Mice Model Market.

Furthermore, the rise of personalized medicine techniques and the need for precision oncology solutions highlight the significance of using mice models that can closely mirror human responses to cancer treatments.

Country/Region-wise Acumens

Will Skyrocketing Demand for Personalized Medicine Prove Mercenary for North America?

According to VMR analysts, North America is estimated to dominate the Mice Model Market during the forecast period owing to the continuous technological advancements and investments taking place the field of oncology and, personalized medicine.

The region's ongoing efforts in oncology research are spurred by the high prevalence of cancer and significant government and corporate funding and initiatives dedicated to finding solutions. This causes an increased demand for advanced mise models in cancer research, propelling the growth in this region.

The growing demand for creating targeted medicines based on individual patients' genetic profiles involves the use of sophisticated mice models that effectively represent human genetic variation. This is raising the need for more specialized and accurate mouse models for the development of patient-specific medical therapies in North America.

Furthermore, the significant presence of established regional firms, such as The Jackson Laboratory and Charles River Laboratories, leads to North America's dominance in the Mice Model Market. These industry giants offer a comprehensive selection of high-quality mouse models and research services, increasing the region's appeal to researchers and pharmaceutical companies.

How will the Mice Model Market Progress in Asia Pacific?

Asia Pacific is estimated to grow at the highest CAGR in the Mice Model Market during the forecast period. Growing inclination toward a sedentary lifestyle, dietary changes, and social habits such as smoking and drinking is resulting an increase in new or re-merging chronic diseases or infections such as tuberculosis and COVID-19. Thus, the need to analyze and develop new drugs or treatments to battle these diseases emphasizes on the application of mice models in research and therapeutic development in the region. in the region.

Also, the flourishing pharmaceutical industry in the region to cater to the needs of the healthcare sector is a significant factor leading to the substantial growth of mice models in this market.

Furthermore, increased focus on heart and circulatory diseases, such as diabetes and cardiovascular disease, highlights the importance of comprehensive research tools, with mouse models playing an important role in elucidating disease pathways and facilitating the development of targeted interventions. The application of mice models in the healthcare sector drives the growth of the Mice Model Market in Asia Pacific.

Competitive Landscape

The Mice Model Market continues to grow, driven by an ever-increasing demand for innovative instruments in drug development and disease research. The competitive landscape is highly dynamic, with ongoing innovation and collaboration determining the future of this critical sector.

Some of the prominent players operating in the Mice Model Market include:

The Jackson Laboratory

Charles River Laboratories International, Inc.

Envigo

Taconic Biosciences

Harlan Laboratories

Janvier Labs

Laboratory Animal Research Center

Tokyo Laboratory Animals Co., Ltd.

Biogen Laboratories

Emmes

Eurofins Scientific

Syngenta

Regeneron Pharmaceuticals, Inc.

AbbVie Inc.

Eli Lilly and Company

Roche Holding AG

Novartis AG

Pfizer Inc.

Merck & Co., Inc.

Johnson & Johnson

Latest Developments

In October 2023, Emmes, a drug discovery CRO, and Taconic Biosciences, a prominent provider of genetically modified mice, announced a collaboration to provide researchers with a broader selection of sophisticated mice models for preclinical studies. This alliance hopes to speed up medication development by giving researchers better tools to forecast therapeutic efficacy and safety.

In October 2024, Charles River, a prominent provider of research models and services, expanded its gene editing capabilities through a collaboration with CRISPR Therapeutics. This will allow researchers to create personalized medicine models for more targeted and effective therapies.

In October 2023, The Jackson Laboratory, a pioneer in mice genetics, announced a breakthrough in producing humanized mice models for cancer research. These models have a human immune system, which allows for more precise testing of cancer treatments and tailored medicine techniques.

In September 2023, Regeneron, a leading biopharmaceutical company, and Janssen Pharmaceuticals announced a collaboration to create a novel mice model for investigating Alzheimer's disease. This model will imitate important aspects of human disease, allowing for the development of new treatments.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 DATA MINING
• 2.2 SECONDARY RESEARCH
• 2.3 PRIMARY RESEARCH
• 2.4 SUBJECT MATTER EXPERT ADVICE
• 2.5 QUALITY CHECK
• 2.6 FINAL REVIEW
• 2.7 DATA TRIANGULATION
• 2.8 BOTTOM-UP APPROACH
• 2.9 TOP DOWN APPROACH
• 2.10 RESEARCH FLOW
• 2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

• 3.1 MARKET OVERVIEW
• 3.2 GLOBAL MICE MODEL MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
• 3.3 GLOBAL MICE MODEL MARKET, BY TYPE (USD MILLION)
• 3.4 GLOBAL MICE MODEL MARKET, BY SERVICE (USD MILLION)
• 3.5 GLOBAL MICE MODEL MARKET, BY TECHNOLOGY (USD MILLION)
• 3.6 GLOBAL MICE MODEL MARKET, BY APPLICATION (USD MILLION)
• 3.7 FUTURE MARKET OPPORTUNITIES
• 3.8 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

• 4.1 GLOBAL MICE MODEL MARKET OUTLOOK
  • 4.1.1 MARKET DRIVERS
  • 4.1.2 LARGE NUMBER OF PHARMACEUTICAL R&D ACTIVITIES
• 4.2 MARKET RESTRAINTS
  • 4.2.1 REGULATIONS AND LAWS FOR ETHICAL USE OF ANIMALS IN RESEARCH
• 4.3 MARKET OPPORTUNITIES
  • 4.3.1 EMERGENCE OF CRISPR AS A STRONG TOOL
• 4.4 PORTERS FIVE FORCE MODEL

5 MARKET, BY TYPE

• 5.1 OVERVIEW
• 5.2 INBRED MICE
• 5.3 OUTBRED MICE
• 5.4 GENETICALLY ENGINEERED MICE
• 5.5 CONDITIONED/SURGICALLY MODIFIED MICE
• 5.6 OTHERS

6 MARKET, BY SERVICE

• 6.1 OVERVIEW
• 6.2 BREEDING
• 6.3 CRYOPRESERVATION
• 6.4 QUARANTINE
• 6.5 GENETIC TESTING
• 6.6 OTHERS

7 MARKET, BY TECHNOLOGY

• 7.1 OVERVIEW
• 7.2 CRISPR/CAS9 MICROINJECTION
• 7.3 MICROINJECTION
• 7.4 NUCLEAR TRANSFER
• 7.5 EMBRYONIC STEM CELL INJECTION
• 7.6 OTHERS

8 MARKET, BY APPLICATION

• 8.1 OVERVIEW
• 8.2 ONCOLOGY STUDIES
• 8.3 DIABETES STUDIES
• 8.4 CARDIOVASCULAR STUDIES
• 8.5 IMMUNOLOGY AND INFLAMMATION STUDIES
• 8.6 CENTRAL NERVOUS SYSTEM (CNS) STUDIES
• 8.7 OTHER DISEASE STUDIES

9 MARKET, BY GEOGRAPHY

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 U.S.
  • 9.2.2 CANADA
  • 9.2.3 MEXICO
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 UK
  • 9.3.3 FRANCE
  • 9.3.4 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 JAPAN
  • 9.4.3 INDIA
  • 9.4.4 REST OF ASIA-PACIFIC
• 9.5 ROW
  • 9.5.1 LATIN AMERICA AND MIDDLE EAST

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY DEVELOPMENT STRATEGIES
• 10.3 COMPANY RANKING ANALYSIS

11 COMPANY PROFILES

• 11.1 LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 COMPANY INSIGHTS
  • 11.1.3 SEGMENT BREAKDOWN
  • 11.1.4 PRODUCT BENCHMARKING
  • 11.1.5 KEY DEVELOPMENTS
  • 11.1.6 SWOT ANALYSIS
• 11.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 COMPANY INSIGHTS
  • 11.2.3 SEGMENT BREAKDOWN
  • 11.2.4 PRODUCT BENCHMARKING
  • 11.2.5 SWOT ANALYSIS
• 11.4 THE JACKSON LABORATORY
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 COMPANY INSIGHTS
  • 11.4.3 PRODUCT BENCHMARKING
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
• 11.5 JANVIER LABS
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 COMPANY INSIGHTS
  • 11.5.3 PRODUCT BENCHMARKING
• 11.6 HARBOUR ANTIBODIES BV
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 COMPANY INSIGHTS
  • 11.6.3 PRODUCT BENCHMARKING
  • 11.6.4 KEY DEVELOPMENTS
• 11.7 TRANS GENIC, INC.
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 COMPANY INSIGHTS
  • 11.7.3 SEGMENT BREAKDOWN
  • 11.7.4 PRODUCT BENCHMARKING
  • 11.7.5 KEY DEVELOPMENTS
• 11.8 GENOWAY
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 COMPANY INSIGHTS
  • 11.8.3 SEGMENT BREAKDOWN
  • 11.8.4 PRODUCT BENCHMARKING
  • 11.8.5 KEY DEVELOPMENTS
• 11.9 TACONIC BIOSCIENCES, INC.
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 COMPANY INSIGHTS
  • 11.9.3 PRODUCT BENCHMARKING
• 11.1 ENVIGO
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 COMPANY INSIGHTS
  • 11.10.3 PRODUCT BENCHMARKING
  • 11.10.4 KEY DEVELOPMENTS

LIST OF TABLES

TABLE 1 GLOBAL MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 2 GLOBAL MICE MODEL MARKET, SERVICE, 2017 - 2026 (USD MILLION)

TABLE 3 GLOBAL MICE MODEL MARKET, TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 4 GLOBAL MICE MODEL MARKET, APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 5 GLOBAL MICE MODEL MARKET, BY GEOGRAPHY, 2017 - 2026 (USD MILLION)

TABLE 6 NORTH AMERICA MICE MODEL MARKET, BY COUNTRY, 2017 - 2026 (USD MILLION)

TABLE 7 NORTH AMERICA MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 8 NORTH AMERICA MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 9 NORTH AMERICA MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 10 NORTH AMERICA MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 11 U.S. MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 12 U.S. MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 13 U.S. MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 14 U.S. MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 15 CANADA MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 16 CANADA MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 17 CANADA MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 18 CANADA MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 19 MEXICO MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 20 MEXICO MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 21 MEXICO MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 22 MEXICO MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 23 EUROPE MICE MODEL MARKET, BY COUNTRY, 2017 - 2026 (USD MILLION)

TABLE 24 EUROPE MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 25 EUROPE MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 26 EUROPE MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 27 EUROPE MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 28 GERMANY MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 29 GERMANY MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 30 GERMANY MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 31 GERMANY MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 32 UK MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 33 UK MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 34 UK MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 35 UK MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 36 FRANCE MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 37 FRANCE MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 38 FRANCE MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 39 FRANCE MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 40 REST OF EUROPE MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 41 REST OF EUROPE MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 42 REST OF EUROPE MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 43 REST OF EUROPE MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 44 ASIA PACIFIC MICE MODEL MARKET, BY COUNTRY, 2017 - 2026 (USD MILLION)

TABLE 45 ASIA PACIFIC MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 46 ASIA PACIFIC MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 47 ASIA PACIFIC MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 48 ASIA PACIFIC MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 49 CHINA MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 50 CHINA MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 51 CHINA MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 52 CHINA MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 53 JAPAN MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 54 JAPAN MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 55 JAPAN MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 56 JAPAN MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 57 INDIA MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 58 INDIA MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 59 INDIA MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 60 INDIA MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 61 REST OF ASIA-PACIFIC MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 62 REST OF ASIA-PACIFIC MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 63 REST OF ASIA-PACIFIC MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 64 REST OF ASIA-PACIFIC MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 65 ROW MICE MODEL MARKET, BY COUNTRY, 2017 - 2026 (USD MILLION)

TABLE 66 ROW MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 67 ROW MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 68 ROW MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 69 ROW MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 70 LATIN AMERICA MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 71 LATIN AMERICA MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 72 LATIN AMERICA MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 73 LATIN AMERICA MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 74 MIDDLE EAST MICE MODEL MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 75 MIDDLE EAST MICE MODEL MARKET, BY SERVICE, 2017 - 2026 (USD MILLION)

TABLE 76 MIDDLE EAST MICE MODEL MARKET, BY TECHNOLOGY, 2017 - 2026 (USD MILLION)

TABLE 77 MIDDLE EAST MICE MODEL MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 78 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT BENCHMARKING

TABLE 79 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY DEVELOPMENTS

TABLE 80 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCT BENCHMARKING

TABLE 81 THE JACKSON LABORATORY: PRODUCT BENCHMARKING

TABLE 82 THE JACKSON LABORATORY: KEY DEVELOPMENTS

TABLE 83 JANVIER LABS: PRODUCT BENCHMARKING

TABLE 84 HARBOUR ANTIBODIES BV: PRODUCT BENCHMARKING

TABLE 85 HARBOUR ANTIBODIES BV: KEY DEVELOPMENTS

TABLE 86 TRANS GENIC, INC.: PRODUCT BENCHMARKING

TABLE 87 TRANS GENIC, INC.: KEY DEVELOPMENTS

TABLE 88 GENOWAY: PRODUCT BENCHMARKING

TABLE 89 GENOWAY: KEY DEVELOPMENTS

TABLE 90 TACONIC BIOSCIENCES, INC.: PRODUCT BENCHMARKING

TABLE 91 ENVIGO: PRODUCT BENCHMARKING

TABLE 92 ENVIGO: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 GLOBAL MICE MODEL MARKET SEGMENTATION

FIGURE 2 RESEARCH TIMELINES

FIGURE 3 DATA TRIANGULATION

FIGURE 4 MARKET RESEARCH FLOW

FIGURE 5 DATA SOURCES

FIGURE 6 GLOBAL MICE MODEL MARKET OVERVIEW

FIGURE 7 GLOBAL MICE MODEL MARKET GEOGRAPHICAL ANALYSIS, 2019-2026

FIGURE 8 GLOBAL MICE MODEL MARKET, BY TYPE (USD MILLION)

FIGURE 9 GLOBAL MICE MODEL MARKET, BY SERVICE (USD MILLION)

FIGURE 10 GLOBAL MICE MODEL MARKET, BY TECHNOLOGY (USD MILLION)

FIGURE 11 GLOBAL MICE MODEL MARKET, BY APPLICATION (USD MILLION)

FIGURE 12 FUTURE MARKET OPPORTUNITIES

FIGURE 13 NORTH AMERICA DOMINATED THE MARKET IN 2018

FIGURE 14 GLOBAL MICE MODEL MARKET OUTLOOK

FIGURE 15 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND IN 2017-2024 (USD BILLION)

FIGURE 16 PORTERS FIVE FORCE MODEL

FIGURE 17 GLOBAL MICE MODEL MARKET, BY TYPE

FIGURE 18 GLOBAL MICE MODEL MARKET, BY SERVICE

FIGURE 19 GLOBAL MICE MODEL MARKET, BY TECHNOLOGY

FIGURE 20 GLOBAL MICE MODEL MARKET, BY APPLICATION

FIGURE 21 GLOBAL MICE MODEL MARKET, BY GEOGRAPHY, 2017 - 2026 (USD MILLION)

FIGURE 22 NORTH AMERICA MARKET SNAPSHOT

FIGURE 23 EUROPE MARKET SNAPSHOT

FIGURE 24 ASIA PACIFIC MARKET SNAPSHOT

FIGURE 25 ROW MARKET SNAPSHOT

FIGURE 26 KEY STRATEGIC DEVELOPMENTS

FIGURE 27 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY INSIGHT

FIGURE 28 LABORATORY CORPORATION OF AMERICA HOLDINGS: SEGMENT BREAKDOWN

FIGURE 29 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS

FIGURE 30 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY INSIGHT

FIGURE 31 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SEGMENT BREAKDOWN

FIGURE 32 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SWOT ANALYSIS

FIGURE 33 THE JACKSON LABORATORY: COMPANY INSIGHT

FIGURE 34 THE JACKSON LABORATORY: SWOT ANALYSIS

FIGURE 35 JANVIER LABS: COMPANY INSIGHTS

FIGURE 36 HARBOUR ANTIBODIES BV: COMPANY INSIGHT

FIGURE 37 TRANS GENIC, INC.: COMPANY INSIGHT

FIGURE 38 TRANS GENIC, INC.: SEGMENT BREAKDOWN

FIGURE 39 GENOWAY: COMPANY INSIGHT

FIGURE 40 GENOWAY: SEGMENT BREAKDOWN

FIGURE 41 TACONIC BIOSCIENCES, INC.: COMPANY INSIGHT

FIGURE 42 ENVIGO: COMPANY INSIGHT